Wood­ford forced to write down val­ues of hold­ings; No­var­tis show­cas­es pos­i­tive PhI­II MS da­ta

Neil Wood­ford‘s in­vest­ment trust was forced to write down the val­ue of one its hold­ings to­day by just un­der $40 mil­lion, an­oth­er tum­ble in what’s be­come a long-run­ning land­slide for the once mar­quee firm. Once one of Britain’s most suc­cess­ful stock pick­ers and a promi­nent sup­port­er of the na­tion’s biotech in­dus­try, Wood­ford has found him­self in the crosshairs since he sus­pend­ed the Eq­ui­ty In­come Fund af­ter years of un­der­per­for­mance and months of mas­sive with­drawals. The name of the writ­ten-down hold­ing is yet to be an­nounced.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.